Improved accuracy of co-morbidity coding over time after the introduction of ICD-10 administrative data. by Januel, Jean-Marie et al.
RESEARCH ARTICLE Open Access
Improved accuracy of co-morbidity coding over
time after the introduction of ICD-10
administrative data
Jean-Marie Januel1*, Jean-Christophe Luthi1,2, Hude Quan4,5, François Borst3, Patrick Taffé1, William A Ghali4,5,6 and
Bernard Burnand1
Abstract
Background: Co-morbidity information derived from administrative data needs to be validated to allow its regular
use. We assessed evolution in the accuracy of coding for Charlson and Elixhauser co-morbidities at three time
points over a 5-year period, following the introduction of the International Classification of Diseases, 10th Revision
(ICD-10), coding of hospital discharges.
Methods: Cross-sectional time trend evaluation study of coding accuracy using hospital chart data of 3’499
randomly selected patients who were discharged in 1999, 2001 and 2003, from two teaching and one non-teaching
hospital in Switzerland. We measured sensitivity, positive predictive and Kappa values for agreement between
administrative data coded with ICD-10 and chart data as the ‘reference standard’ for recording 36 co-morbidities.
Results: For the 17 the Charlson co-morbidities, the sensitivity - median (min-max) - was 36.5% (17.4-64.1) in 1999,
42.5% (22.2-64.6) in 2001 and 42.8% (8.4-75.6) in 2003. For the 29 Elixhauser co-morbidities, the sensitivity was 34.2%
(1.9-64.1) in 1999, 38.6% (10.5-66.5) in 2001 and 41.6% (5.1-76.5) in 2003. Between 1999 and 2003, sensitivity estimates
increased for 30 co-morbidities and decreased for 6 co-morbidities. The increase in sensitivities was statistically
significant for six conditions and the decrease significant for one. Kappa values were increased for 29 co-morbidities
and decreased for seven.
Conclusions: Accuracy of administrative data in recording clinical conditions improved slightly between 1999 and
2003. These findings are of relevance to all jurisdictions introducing new coding systems, because they
demonstrate a phenomenon of improved administrative data accuracy that may relate to a coding ‘learning curve’
with the new coding system.
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Background
Administrative data are widely used to examine various
health and policy related issues, such as health outcomes,
utilisation of services, quality of care and surveillance
[1-6]. One major asset of using administrative data is that
they cover large populations, are ready to be analyzed,
and contain detailed clinical and outcome information.
There have been a number of studies assessing the accu-
racy of administrative data [7-16]. However, the validity
of using administrative data for research purposes has
been questioned repetitively [7-10] because several stu-
dies demonstrate variable and sometimes suboptimal
agreement between chart data and administrative data
[11-16].
Studies have shown variable accuracy across jurisdic-
tions. Relatively little is known about trends over time in
accuracy of coding and, in particular, coding “learning
curves” after introduction of a new coding system.
Canada, for example, introduced the International Classi-
fication of Diseases, 10th revision, (ICD-10) [17] recently,
between 2002 and 2007, [18] with each province doing so
on a different schedule, and there was no available
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information on the possible existence of coding learning
curve effects on data validity. One study assessed the
accuracy one year after the introduction in Alberta
(Canada), [19] but without time trend investigation. ICD-
10 was introduced in Switzerland in 1998. This study
assesses data accuracy in the five years following the
implementation of ICD-10 in the French part of Switzer-
land, with assessments of administrative data accuracy
relative to charts in 1999, 2001, and 2003. Our primary
research question of interest was to determine whether
there was evidence of improved data accuracy.
Methods
Study Population
This time trend evaluation study was based on three cross-
sectional analyses of randomly selected administrative dis-
charge records from three Swiss hospitals collected in
1999, 2001 and 2003. Two teaching hospitals and one
non-teaching were included. Each of the two teaching hos-
pitals has more than 1000 beds and over 30’000 discharges
per year, while the non-teaching hospital has 300 beds and
12’000 discharges per year. For these three hospitals, the
data were used for reimbursement at the date of the study
start. Professional coders were nurses with at least 5 years
of clinical practice and at least one year of training as a
coder. Professional coders were introduced before 1999
for one teaching hospital and between 1999 and 2001 for
the one other teaching and the non-teaching hospital. We
randomly selected 500 records among patient discharges
in 1999, 2001 and 2003 from each hospital, thus collecting
1500 records from each hospital, totalling 4’500 records.
We included patients 16 years of age or older who stayed
in the hospital for at least 24 hours and were discharged
from any acute care wards from these hospitals. Of the
4’500 randomly selected patients, we excluded 1001
patients for the following reasons: eight patients because
they left the hospital against medical advice, three because
their age was less than 16 years, 11 because their length of
stay (LOS) was less than 24 hours, and 979 because their
charts could not be located.
The study was approved by the respective ethic com-
mittees of the three cantons.
Chart Data Abstraction
We identified charts through the chart number recorded
in the administrative data. Chart abstraction was per-
formed by two trained research nurses who read the
entire chart, including admission and transfer notes, phy-
sician daily progress notes and orders, consultation
notes, operative notes, diagnostic imaging and exam
reports, discharge and narrative summaries and pathol-
ogy reports. One research nurse undertook the data
abstraction for each chart. The detailed chart review
process took approximately 45 minutes per chart, on
average. The reviewers extracted information about
patient age and sex, length of stay, death and Charlson
[20] and Elixhauser [21] co-morbidities. Presence or
absence of these co-morbidities was determined using
the definitions described by Charlson et al. [20] and a
chart abstraction instrument developed by a Canadian
research team [19] for determining the Elixhauser co-
morbidities [21]. All diagnoses corresponding to the defi-
nition of each non-redundant co-morbidity from Charl-
son and Elixhauser indices were identified by the two
research nurses in the medical records. We excluded the
condition ‘Other neurological disorders’ from the chart
review process because its definition is too broad and
vague. The inter-rater agreement between the two
reviewers was assessed before the chart abstraction pro-
cess. Kappa values ranged from -0.04 to 1.00 among 50
charts. Out of 30 co-morbidities assessed, 16 had sub-
stantial agreement (Kappa: 0.60-0.79), 10 had moderate
agreement (Kappa: 0.40-0.59), and 4 had fair or poor
agreement (Kappa< 0.40) [22]. We further trained the
reviewers through discussion of results from this agree-
ment test. Chart data abstraction was performed between
2005 and 2007.
Defining Co-morbidities in Administrative Data
Charlson [20] and Elixhauser [21] indices were derived
from ICD10 coding algorithms. Each administrative hos-
pital discharge record contains a unique personal identi-
fication number, patient chart number, and up to 30
diagnoses in one teaching hospital, and up to 10 diag-
noses in the other teaching hospital and in the non-
teaching hospital. We used a recently developed ICD-10
coding algorithm [23] to define the 36 non-redundant
Charlson and Elixhauser co-morbidities in these admin-
istrative data.
Matching comparisons between ICD-10 data and Chart
Review Data
Comparisons were based on the match between ICD-10
data and chart review data for the same hospital dis-
charges, in the three hospitals samples and studied years,
respectively, using the unique personal identification
number. As explained above, we developed two compara-
tive databases, one using ICD-10 data and the other using
chart review. For each hospital discharge, we matched
chart review data and non-redundant co-morbidities
from Charlson and Elixhauser indices that had been iden-
tified using ICD-10. Then, we performed pairwise ana-
lyses that were constituted by ICD-10 data and chart
review data for all hospital discharges in our study and
for all non-redundant Charlson and Elixhauser indices
co-morbidity, respectively.
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Statistical Analysis
The prevalence of the Charlson and Elixhauser co-mor-
bidities in administrative data and chart review, as well
as their difference (i.e. prevalence difference, ΔChart-ICD),
were assessed for each year and co-morbidity. Ninety-
five percent confidence intervals for ΔChart-ICD were cal-
culated using the formula for the comparison of two
binomial proportions, accounting for sampling weights.
The heterogeneity in prevalence differences across the
three years was assessed by the Cochran Q statistic for
each co-morbidity, respectively [24].
The accuracy of the administrative data was determined
using chart data as the ‘reference standard’. We calculated
the sensitivity (Se) and positive predictive value (PPV) for
each co-morbidity and year. We assessed the impact of
the year using logistic regression analysis for survey sam-
pling and global Wald test. The dependent variable was
the “sensitivity” and the study year was a covariate (the
reference year was 1999 and an odds-ratio was estimated
for 2001 and 2003, respectively). A P-value < 0.05 was
considered as significant.
Using a different perspective, we also calculated
Cohen’s Kappa index value along with its 95% confidence
interval to assess the agreement between the ICD-10 and
Chart review for each co-morbidity and year. These 95%
CI intervals were used to assess pairwise differences
between the indexes [25,26]. No multiple testing adjust-
ments were performed [27]. Finally, the co-morbidity
counts, determined for both Charlson and Elixhauser
items, for the ICD-10 and chart review data were
grouped into 4 ordinal categories. The categories were 0,
1, 2 or 3, and 4 or higher for the Charlson index, and 0, 1
and 2, 3-5, and 6 and higher for the Elixhauser index. A
weighted Kappa index between ICD-10 and chart review
data, with weights 1-|i-j|/(4-1) where i and j indicates the
rows and columns of the 4 categories, respectively, was
calculated for each year.
Various sampling fractions were used, as the number
of missing or excluded patients differed across hospitals
and years: 0.962 (481/500) for the first teaching hospital,
0.722 (361/500) for the second teaching hospital and
0.632 (316/500) for the non-teaching hospital in 1999,
0.952 (476/500) for first teaching hospital, 0.806 (403/
500) for second teaching hospital and 0.632 (316/500)
for the non-teaching hospital in 2001, and 0.992 (496/
500) for first teaching hospital, 0.910 (455/500) for the
second teaching hospital and 0.390 (195/500) for the
non-teaching hospital in 2003.
All statistical analyses were performed using the SAS
Software version 9.2, Cary, NC, USA.
Results
We analyzed 3’499 patient records (77.8% of 4500). The
mean age (standard deviation) was 58.1 years (19.2) in
1999, 57.3 (20.5) in 2001, and 55.3 (20.1) in 2003 (p =
0.42). The sex ratio (Female/Male) was 1.14 in 1999,
1.08 in 2001, and 1.05 in 2003 (p = 0.58).
The mean number of diagnoses coded was 4.01 (2.8),
across all hospitals. The mean number of diagnoses dif-
fered between the three hospitals (p < 0.001): 4.99 (2.8)
in the first teaching hospital with up to 30 diagnoses
coded, 3.29 (2.7) in the second teaching hospital with up
to 10 diagnoses coded, and 3.33 (2.4) in the non teaching
hospital with up to 10 diagnoses coded. Table 1 presents
the prevalence of the 36 co-morbidities by data source
across study years. In general, administrative data under-
reported 33 conditions but reported similar levels of
moderate and severe liver disease, any tumour and lym-
phoma compared to chart review data. The prevalence
difference, ΔChart-ICD, ranged from -0.5% to 15.1% in
1999, from -0.6% to 16.1% in 2001, and from -1.7% to
12.2% in 2003. The difference in trend ΔChart-ICD across
the three years was significant for 33 co-morbidities. No
significant differences were observed for myocardial
infarction, any tumor and metastatic cancer.
Indicators of accuracy of administrative data and of
agreement between chart review data and administrative
data by study year are presented in Table 2. For the 17
variables of the Charlson co-morbidity index, sensitivities
ranged from 17.4% to 64.1% (median 36.5%) in 1999, from
22.2% to 64.6% (median 42.5%) in 2001 and from 8.4% to
75.6% (median 42.8%) in 2003. For the 29 Elixhauser co-
morbidities, sensitivities ranged from 1.9% to 64.1% (med-
ian 34.2%) in 1999, from 10.5% to 66.5% (median 38.6%)
in 2001 and from 5.1% to 76.5% (median 41.6%) in 2003.
Out of 36 conditions, there was an increase in sensitivity
for the 30 following conditions between 1999 and 2003:
cardiac arrhythmias*, myocardial infarction, peripheral
vascular disease, pulmonary circulation disorders, valvular
disease*, cerebrovascular disease, hemiplegia or paraplegia,
hypertension*, diabetes without complication, hypothyr-
oidism, peptic ulcer, peptic ulcer excluding bleeding, liver
disease, mild liver disease, moderate and severe liver dis-
ease, any tumour, metastatic cancer*, solid tumour with-
out metastasis, blood loss anaemia, deficiency anaemia,
fluid electrolytic disorder*, weight loss, obesity*, alcohol
abuse, drug abuse, dementia, psychosis, depression (statis-
tically significant for 6 of those(*)). A decrease was
observed for the 6 following conditions: diabetes with
complications, lymphoma, renal failure, rheumatic dis-
ease*, AIDS/HIV, coagulopathy (statistically significant for
only 1 of them (*)).
Kappa values ranged from 0.05 to 0.78 in 1999, from
0.17 to 0.71 in 2001 and from 0.06 to 0.77 in 2003
across the 36 non redundant conditions from both
Charlson and Elixhauser (see Table 2 and Figure 1).
Between 1999 and 2003, Kappa values increased for 29
co-morbidities and decreased for seven (Table 2). The
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Table 1 Prevalence of Charlson and Elixhauser Co-morbidities in ICD-10 Administrative and Chart Data by Study Year, N = 3’449*
Prevalence of co-morbidities Prevalence difference, ΔChart-ICD
1999
(n = 1’158)
2001
(n = 1’195)
2003
(n = 1’146)
1999 2001 2003
COMORBIDITIES ICD-10 Chart ICD-10 Chart ICD-10 Chart Δ (95%CI) Δ (95%CI) Δ (95%CI) P-value**
N1 N2 N1 N2 N1 N2 % % % % % %
Cardiac arrhythmias2 85 (5.7) 237 (15.9) 133 (8.9) 292 (19.5) 144 (9.6) 229 (15.3) 10.2 (9.1-11.3) 10.6 (9.3-11.9) 5.6 (4.0-7.3) < 0.001
Congestive heart failure1,2 76 (5.1) 302 (20.2) 80 (5.3) 285 (19.0) 85 (5.6) 268 (17.9) 15.1 (13.8-16.4) 13.7 (12.5-14.1) 12.2 (10.5-14.0) < 0.001
Myocardial infraction1(a) 49 (3.2) 64 (4.3) 57 (3.8) 48 (3.2) 57 (3.8) 70 (4.7) 1 (0.3-1.8) -0.6 (-1.3-0.1) 0.9 (-0.4-2.2) 0.437
PVD1,2 43 (2.9) 159 (10.6) 74 (4.9) 316 (21.0) 59 (3.9) 168 (11.2) 7.7 (6.9-8.5) 16.1 (14.9-17.3) 7.3 (6.1-8.4) < 0.001
PCD2 20 (1.4) 49 (3.3) 31 (2.1) 68 (4.5) 27 (1.8) 55 (3.7) 1.9 (1.4-2.5) 2.5 (1.8-3.1) 1.9 (1.2-2.5) < 0.001
Valvular disease2 45 (3.0) 134 (8.9) 61 (4.1) 186 (12.4) 103 (6.9) 149 (10.0) 6 (5.1-6.8) 8.3 (7.2-9.4) 3.1 (1.6-4.6) < 0.001
CEVD1,2 58 (3.9) 127 (8.5) 73 (4.9) 162 (10.8) 74 (4.9) 123 (8.2) 4.6 (3.6-5.6) 5.9 (4.9-7.0) 3.3 (2.0-4.5) < 0.001
Hemiplegia or paraplegia1,2 17 (1.1) 88 (5.9) 31 (2.1) 101 (6.8) 36 (2.4) 90 (6.0) 4.7 (4.1-5.4) 4.7 (4.0-5.5) 3.6 (2.5-4.7) < 0.001
Hypertension 2 230 (15.4) 437 (29.2) 311 (20.7) 443 (29.6) 366 (24.4) 457 (30.5) 13.8 (12.2-15.4) 8.9 (7.3-10.5) 6.1 (3.6-8.5) < 0.001
CPD1,2 57 (3.8) 161 (10.8) 87 (5.8) 174 (11.6) 109 (7.3) 205 (13.6) 7 (6.0-7.9) 5.8 (4.8-6.8) 6.4 (4.9-7.9) < 0.001
Diabetes
- with complication1,2 23 (1.5) 42 (2.8) 20 (1.4) 33 (2.2) 25 (1.7) 53 (3.6) 1.4 (0.6-2.3) 1.5 (0.6-2.5) 0.8 (-0.9-2.5) < 0.001
- without complication1,2 76 (5.1) 97 (6.5) 95 (6.3) 118 (7.8) 132 (8.8) 144 (9.6) 1.2 (0.7-1.8) 0.8 (0.4-1.3) 1.9 (1.5-2.3) < 0.001
Hypothyroidism2 14 (0.9) 33 (2.2) 40 (2.6) 63 (4.2) 35 (2.3) 64 (4.3) 1.3 (0.8-1.7) 1.6 (1.0-2.2) 2 (1.0-3.0) < 0.001
Peptic ulcer1 15 (1.0) 59 (3.9) 24 (1.6) 49 (3.3) 19 (1.3) 68 (4.5) 3 (2.2-3.7) 1.7 (1.1-2.2) 3.3 (2.3-4.2) < 0.001
Peptic ulcer (ex. bleeding) 2 3 (0.2) 44 (2.9) 10 (0.6) 41 (2.7) 8 (0.6) 57 (3.8) 2.7 (2.1-3.3) 2.1 (1.6-2.6) 3.3 (2.4-4.1) < 0.001
Liver disease2 36 (2.4) 89 (5.9) 40 (2.6) 93 (6.2) 46 (3.1) 101 (6.7) 3.5 (2.8-4.3) 3.6 (2.9-4.3) 3.7 (2.5-4.8) < 0.001
- Mild liver disease1 32 (2.1) 49 (3.3) 34 (2.3) 41 (2.7) 38 (2.6) 52 (3.5) 1.2 (0.6-1.8 0.4 (-0.1-0.9) 0.9 (0.2-1.7) < 0.001
- MSLD1 6 (0.4) 4 (0.3) 10 (0.7) 9 (0.6) 19 (1.2) 9 (0.6) -0.1 (-0.3-0.1) -0.1 (-0.3-0.1) -0.6 (-1.1–0.2) 0.028
Any Tumor1 132 (8.8) 124 (8.2) 136 (9.1) 142 (9.5) 157 (10.4) 146 (2.2) -0.5 (-1.6-0.5) 0.4 (-0.6-1.4) -0.7 (-2.4-0.9) 0.627
Lymphoma2 18 (1.2) 29 (2.5) 26 (1.7) 30 (2.8) 16 (1.1) 25 (2.2) 1.3 (0.8-1.9) 0.6 (0.2-1.0) 1.1 (0.4-1.8) < 0.001
Metastatic cancer1,2 40 (2.7) 120 (8.1) 75 (5.0) 119 (8.0) 71 (4.8) 119 (7.9) -0.4 (-1.5-0.6) 0.6 (-0.4-1.7) -1.7 (-3.2–0.1) 0.842
STWM2 125 (8.3) 117 (7.9) 140 (9.3) 148 (10.0) 153 (10.2) 128 (8.5) 5.4 (4.5-6.3) 3 (2.0-3.9) 3.2 (1.8-4.6) < 0.001
Renal failure1,2 65 (4.3) 147 (9.8) 61 (4.1) 152 (10.1) 59 (4.0) 150 (10.0) 5.5 (4.6-6.4) 6 (5.2-6.8) 6 (5.1-6.9) < 0.001
Rheumatic disease1,2 10 (0.7) 27 (1.8) 17 (1.1) 29 (1.9) 14 (0.9) 49 (3.2) 1.1 (0.7-1.6) 0.8 (0.3-1.3) 2.3 (1.7-2.9) < 0.001
AIDS/HIV1,2 9 (0.6) 15 (1.0) 4 (0.2) 7 (0.5) 3 (0.2) 13 (0.9) 0.3 (0.0-0.7) 0.2 (0.1-0.4) 0.7 (0.4-0.9) < 0.001
Blood loss anemia2 3 (0.2) 55 (3.7) 11 (0.7) 80 (5.4) 12 (0.8) 99 (6.6) 3.5 (3.1-4.0) 4.6 (4.2-5.0) 5.8 (5.2-6.3) < 0.001
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Table 1 Prevalence of Charlson and Elixhauser Co-morbidities in ICD-10 Administrative and Chart Data by Study Year, N = 3?’?449* (Continued)
Deficiency anemia2 11 (0.8) 59 (3.9) 25 (1.7) 79 (5.3) 17 (1.2) 65 (4.3) 3.2 (2.5-3.9) 3.6 (2.9-4.2) 3.2 (2.1-4.2) < 0.001
Coagulopathy2 17 (1.1) 45 (3.0) 18 (1.2) 64 (4.3) 30 (2.0) 95 (6.3) 1.9 (1.4-2.4) 3.1 (2.6-3.6) 4.3 (3.3-5.4) < 0.001
FED2 20 (1.4) 106 (7.1) 32 (2.2) 123 (8.2) 59 (4.0) 152 (10.1) 5.7 (5.1-6.3) 6.1 (5.4-6.7) 6.2 (5.0-7.3) < 0.001
Weight loss2 8 (0.5) 58 (3.9) 14 (0.9) 82 (5.5) 10 (0.7) 63 (4.2) 3.3 (2.8-3.8) 4.5 (3.9-5.1) 3.5 (2.9-4.1) < 0.001
Obesity2 33 (2.2) 104 (7.0) 48 (3.2) 99 (6.6) 62 (4.1) 110 (7.3) 4.7 (4.1-5.4) 3.4 (2.6-4.2) 3.2 (1.9-4.5) < 0.001
Alcohol abuse2 41 (2.7) 92 (6.1) 62 (4.2) 97 (6.5) 67 (4.5) 116 (7.7) 3.4 (2.7-4.1) 2.3 (1.6-3.1) 3.3 (2.1-4.5) < 0.001
Drug abuse2 15 (1.0) 31 (2.1) 14 (1.0) 28 (1.8) 27 (1.8) 52 (3.4) 1 (0.6-1.4) 0.9 (0.6-1.2) 1.6 (1.0-2.3) < 0.001
Dementia1 22 (1.5) 32 (2.2) 19 (1.3) 30 (2.0) 20 (1.3) 23 (1.6) 0.7 (0.1-1.2) 0.7 (0.3-1.2) 0.2 (-0.1-0.6) < 0.001
Psychosis2 3 (0.2) 23 (1.6) 14 (1.0) 26 (1.7) 11 (0.7) 23 (1.5) 1.3 (0.9-1.7) 0.8 (0.4-1.2) 0.8 (0.3-1.3) < 0.001
Depression2 56 (3.7) 121 (8.1) 83 (5.5) 140 (9.3) 92 (6.2) 154 (10.3) 4.4 (3.5-5.2) 3.8 (2.8-4.8) 4.1 (2.7-5.5) < 0.001
Abbreviations: PCD = Pulmonary circulation disorders, PVD = Peripheral vascular disease, CEVD = Cerebrovascular disease, CPD = Chronic pulmonary disease, MSLD = Moderate and severe liver disease, STWM =
Solid tumour without metastasis, FED = Fluid and electrolytic disorders.
* Sample size without weighted sampling fraction (i.e., observed sample size).
**Cochran Q test for heterogeneity of prevalence difference (ΔChart-ICD) between chart review and administrative data across years.
1 Charlson co-morbidities; 2 Elixhauser co-morbidities.
(a) Only recent myocardial infarction.
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Figure 1 shows Kappa values comparing administrative
data and chart data in 2001 and 2003 in relation to
1999 with more details. Of 36 conditions, the Kappa
values increased for 23 conditions (see the upper right
quadrant) and four decreased (see lower left quadrant)
in 2001 and 2003 compared with 1999. Kappa values for
three conditions increased in 2001 (see lower right
quadrant) but decreased in 2003, and for six conditions
decreased in 2001 but increased in 2003 (see upper left
quadrant) compared with 1999. In most cases the
Table 2 Agreement and Accuracy between Chart and Administrative Data by Study Year, N = 3’449*
1999
(n = 1’158)
2001
(n = 1’195)
2003
(n = 1’146)
Comparison across
years
COMORBIDITIES Se PPV Kappa Se PPV Kappa Se PPV Kappa P-value**
% % k (95% CI) % % k (95% CI) % % k (95% CI) Se PPV
Cardiac arrhythmias2 35.3 98.8 0.48 (0.38-0.54) 43.9 96.4 0.55 (0.48-0.62) 56.1 89 0.65 (0.57-0.70)††† 0.001 0.022
Congestive heart failure1,2 20.8 82.3 0.27 (0.17-0.32) 23.8 84.9 0.31 (0.22-0.37) 26.3 83.4 0.38 (0.28-0.44) 0.193 0.898
Myocardial infraction1(a) 43 56.9 0.47 (0.36-0.60) 71.5 61.4 0.65 (0.52-0.75) 56.2 69 0.6 (0.48-0.72) 0.109 615
PVD1,2 24.7 90.4 0.35 (0.22-0.41) 22.2 94.3 0.3 (0.20-0.34) 33.1 94.6 0.4 (0.30-0.47) 0.391 0.792
PCD2 34.1 82.9 0.47 (0.33-0.62) 36.1 79 0.5 (0.36-0.62) 38.6 78.5 0.51 (0.37-0.64) 0.934 0.984
Valvular disease2 31.3 93.8 0.44 (0.34-0.54) 30.8 93.7 0.43 (0.32-0.50) 60.6 88 0.65 (0.56-0.72)††/††† 0.001 0.816
CEVD1,2 35.7 78.1 0.46 (0.35-0.55) 31.7 71.2 0.43 (0.33-0.51) 47.3 78.6 0.54 (0.44-0.63) 0.18 0.951
Hemiplegia or araplegia1,2 17.4 90.6 0.31 (0.19-0.43) 26.1 96.2 0.39 (0.27-0.50) 37 94.3 0.45 (0.32-0.56) 0.307 0.86
Hypertension 2 49.6 94.1 0.6 (0.53-0.64) 66.5 94.9 0.71 (0.67-0.76)† 76.5 95.4 0.77 (0.73-0.81) ††/††† < 0.001 0.921
CPD1,2 30.6 87.2 0.45 (0.35-0.53) 47.5 94.8 0.6 (0.52-0.67)† 44.2 82.8 0.54 (0.44-0.59) 0.052 0.097
Diabetes
- with complication1,2 45.2 81.9 0.57 (0.42-0.72) 43 69.6 0.52 (0.35-0.68) 41.3 87 0.55 (0.42-0.68) 0.969 0.394
- without complication1,2 60 76.7 0.69 (0.59-0.76) 64.6 80.3 0.7 (0.62-0.77) 75.6 82.6 0.72 (0.64-0.78) 0.584 0.83
Hypothyroidism2 39 92.5 0.59 (0.40-0.74) 57.8 95.8 0.71 (0.59-0.80) 44.2 82 0.61 (0.47-0.72) 0.461 0.5
Peptic ulcer1 21.2 85.8 0.33 (0.19-0.49) 42 86 0.55 (0.38-0.67) 27.8 100 0.47 (0.32-0.60) 0.221 0.866
Peptic ulcer (ex. bleeding) 2 3.1 40 0.05 (0.00-0.23) 15.4 65.4 0.24 (0.10-0.41) 7.4 50.5 0.16 (0.05-0.33) 0.326 0.685
Liver disease2 36.3 90.3 0.5 (0.39-0.62) 35.8 84.4 0.48 (0.39-0.60) 44.8 97.8 0.63 (0.51-0.72) 0.329 0.265
- Mild liver disease1 49.4 81.4 0.6 (0.47-0.73) 48.4 68.3 0.56 (0.41-0.70) 51 78.5 0.66 (0.52-0.76) 0.916 0.299
- MSLD1 27.3 50 0.35 (0.08-0.78) 37.2 35.9 0.36 (0.14-0.63) 87.5 62.2 0.73 (0.46-0.90) 0.169 0.495
Any Tumor1 42.8 40.2 0.36 (0.28-0.46) 52.1 54.1 0.48 (0.39-0.55) 47.8 44.4 0.44 (0.35-0.52) 0.445 0.247
Lymphoma1,2 46.9 100 0.2 - 67.1 91.1 0.21 - 43.1 87.8 0.06 - 0.197 -
Metastatic cancer1,2 32 97.4 0.49 (0.38-0.59) 57.2 90.6 0.68 (0.59-0.75) 56.6 94.2 0.69 (0.61-0.74)†† 0.007 0.502
STWM2 40.6 39.7 0.35 (0.26-0.44) 50 54.5 0.47 (0.38-0.54) 42.1 35.5 0.32 (0.25-0.42) 0.388 0.019
Renal failure1,2 42.7 97.6 0.61 (0.51-0.68) 38.2 94.8 0.52 (0.43-0.60) 36.6 92.8 0.49 (0.38-0.56)††† 0.204 0.351
Rheumatic disease1,2 37.2 100 0.54 - 55.4 93.8 0.69 - 26.8 92.2 0.41 - 0.049 -
AIDS/HIV1,2 64.1 100 0.78 (0.55-0.92) 50 100 0.67 (0.29-0.88) 16.8 66.7 0.27 (0.08-0.57) 0.086 -
Blood loss anemia2 1.9 39.7 0.03 (0.02-0.16) 10.5 74.9 0.17 (0.07-0.29) 5.1 40.8 0.08 (0.00-0.16) 0.163 0.477
Deficiency anemia2 12.7 66.2 0.2 (0.09-0.38) 20.1 67.2 0.29 (0.17-0.41) 13.4 50 0.22 (0.11-0.39) 0.691 0.623
Coagulopathy2 34.2 91.7 0.49 (0.34-0.65) 24.8 92.8 0.38 (0.24-0.51) 27.5 87.9 0.4 (0.28-0.52) 0.561 0.97
FED2 16.6 85.5 0.26 (0.15-0.37) 21.3 84.6 0.32 0.20-0.41) 32.9 86.7 0.43 (0.33-0.51) 0.031 0.978
Weight loss2 14.1 100 0.24 - 17.1 100 0.28 - 14.6 100 0.25 0.816 -
Obesity2 29.4 92.1 0.43 (0.34-0.55) 39.5 81.1 0.51 (0.42-0.63) 51.5 91.7 0.68 (0.57-0.76)††† 0.013 0.21
Alcohol abuse2 39 90.4 0.53 (0.43-0.65) 54.4 84.5 0.64 (0.55-0.74) 51.9 91.2 0.64 (0.55-0.73) 0.183 0.444
Drug abuse2 37.8 76.1 0.5 (0.32-0.67) 47.7 91.4 0.62 (0.45-0.79) 41.8 79.7 0.54 (0.38-0.65) 0.682 0.541
Dementia1 48.8 71.6 0.6 (0.42-0.74) 40.9 64.9 0.49 (0.31-0.66) 53.5 67 0.61 (0.42-0.75) 0.57 0.832
Psychosis2 10.4 70 0.18 (0.05-0.45) 41.2 74.1 0.52 (0.34-0.71) 42 90.5 0.57 (0.35-0.74) 0.112 0.647
Depression2 42.3 92.2 0.56 (0.48-0.67) 56.7 95.7 0.69 (0.60-0.76) 53.9 89.8 0.65 (0.54-0.70) 0.236 0.632
Se = Sensitivity, PPV = Positive predictive value, PCD = Pulmonary circulation disorders, PVD = Peripheral vascular disease, CEVD = Cerebrovascular disease, CPD
= Chronic pulmonary disease, MSLD = Moderate and severe liver disease, STWM = Solid tumour without metastasis, FED = Fluid and electrolytic disorders.
1Charlson co-morbidities; 2Elixhauser co-morbidities.
(a) Only recent myocardial infraction
*Sample size without weighted sampling fraction (i.e., observed sample size)
**Global Wald test
† Difference was significant for comparison between 1999 and 2001, †† between 2001 and 2003, and ††† between 1999 and 2003.
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changes in Kappa values across the years were not sig-
nificant. For 2 co-morbidities the Kappa value increased
significantly between 1999 and 2001, and for three co-
morbidities the Kappa value increased significantly
between 2001 and 2003 (for value increased in the 3
cases). In addition, for 4 co-morbidities the Kappa value
increased significantly between 1999 and 2003.
In addition, weighted Kappa values between chart
review and administrative data were 0.46 (95% CI: 0.44-
0.51) in 1999, 0.52 (95% CI: 0.49-0.56) in 2001, and 0.54
(95% CI: 0.51-0.58) in 2003, when the Charlson index
score was calculated using the weight developed by
Charlson (using categorical variables with index scores
of 0, 1, 2 or 3, and 4 or higher). These weighted Kappa
values were 0.37 (95% CI: 0.34-0.40) in 1999, 0.45 (95%
CI: 0.42-0.48) in 2001, and 0.48 (95% CI: 0.46-0.51) in
2003 when assessing the Elixhauser co-morbidity count
(using categorical variables with co-morbidity counts of
0, 1 and 2, between 3 and 5, and 6 and higher).
Discussion
Our study indicates that the accuracy of administrative
data coded with ICD-10 improved slightly between 1999
and 2003. That improvement was evidenced by the
increase of sensitivity for most co-morbidities across the
five year period. However, we also found that, for some
conditions (i.e. lymphoma, renal failure, rheumatic dis-
eases, AIDS/HIV and coagulopathy), the accuracy of
ICD-10 administrative data decreased somewhat over the
period. These findings are of relevance to all jurisdictions
interested in studying data quality trends as new coding
systems are introduced.
There are several possible explanations for these
results. First, professional coders were increasingly
employed to code charts in Switzerland during the more
recent years of the study period. However, there are few
training programs for coders in Switzerland. Lay persons
or clinically trained nurses and physicians are coding
charts after only a short training period. Therefore, it is
hard to avoid inter-coder variation in the quality of cod-
ing. Second, an APDRG reimbursement system was
introduced in some hospitals. Therefore, this financial
incentive may have triggered coders to code more condi-
tions than previously. In our sample, the average number
of diagnosis codes was 2.99 in 1999, 4.25 in 2001 and
4.91 in 2003. Third, coders’ knowledge and skills in using
ICD-10 coding methods and ICD-10 guidelines may have
improved with time (i.e., a coding ‘learning curve’), con-
tributing to an improved adherence to coding guidelines.
Fourth, administrative data quality improvement initia-
tives in Switzerland have been implemented with the
creation of a coding unit at the Swiss Federal Statistical
Office. This Office has developed and disseminated
national coding rules for standardizing coding methods.
Fifth, coders might have become more aware of the
importance of certain conditions and paid more attention
to coding these conditions. For example, we found that
Kappa was 0.18 in 1999 and increased to 0.52 in 2001
and 0.57 in 2003 for obesity although this condition is
not considered to be important for coding unless it
directly contributes to the hospital stay. Sixth, it is possi-
ble that physicians documented clinical information bet-
ter so that coders could translate the clinical information
into electronic codes more easily. We also found that the
accuracy of six conditions decreased over the study per-
iod. The accuracy of AIDS/HIV dropped dramatically.
The sensitivity decreased from 64.1% in 1999 to 16.8% in
2003. While this drop appears substantial at first glance,
we suspect that random error is a major contributor to
this finding, as a result of the very small sample size used
for judging the accuracy of this variable. In addition, PPV
was rarely equal to 100%. There are several possible
explanations for false positives: incomplete medical
records used in this study; the research nurses could have
missed some clinical diagnosis from chart review. Indeed,
chart review is not a perfect reference standard.
Since the introduction of the ICD-10 coding system,
only a few accuracy studies have been conducted. Our
2003 results for sensitivity and Kappa values were similar
to those obtained in 2003 in a Canadian study [19]. Both
studies employed the same methodology, including study
designs, data collection process and definition of study
variables. In Europe, Gibson and Bridgman [28] com-
pared the accuracy of ICD-10 primary diagnosis coding
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Figure 1 Differences in Kappa Values between 1999, 2001 and
2003 of 36 Conditions Derived from Administrative Data
Relative to Chart Review, N = 36. Kappa value increased for 23
conditions (see the upper right quadrant) and decreased for 4 (see
lower left quadrant) in 2001 and 2003 compared with 1999. Kappa
value increased for 3 conditions in 2001 (see lower right quadrant)
but decreased in 2003, and decreased for 6 conditions in 2001 but
increased in 2003 (see upper left quadrant) compared with 1999.
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in hospital administrative data versus charts. They stu-
died a total of 298 general surgery records from the
North Staffordshire Health Authority, United Kingdom,
in 1996-1997. Coding errors occurred in 8% of records at
the first character level, 9% at the second character level,
24% at the third character level, and 29% at the fourth
character level. A recent study in Australia [29] demon-
strated that the validity of ICD-10 administrative data
was high in 2000 and 2001, two years after the introduc-
tion of the ICD-10 in that country, with sensitivities ran-
ging from 0.58 to 0.97. In the future, more and more
countries will be using ICD-10. The USA have plans to
introduce ICD-10-CM in 2013 [30]. Use of administrative
data and their validation will become increasingly impor-
tant internationally in the future. The World Health
Organisation (WHO) is continuously working on ICD-10
revisions and the production of ICD-11 is planned for
2015 [31]. Swiss administrative data have previously been
studied, especially since the introduction of ICD-10 [17]
in 1998. However, to date, only quality of coding reliabil-
ity studies have been performed in the country [31,32],
that have shown that about two thirds of the primary
diagnosis codes had all five characters correctly coded in
1998 already [33] and that major improvements in the
quality of coding occurred between 1998 and 2003 [34].
Administrative data are commonly used for trend ana-
lyses of conditions and quality of care assessment over
time [19,28,29]. Such studies should be interpreted with
caution. Indeed, we have observed in our study that the
accuracy of several conditions improved or decreased over
time. Such variations in accuracy over time could result in
better or worse identification by time period. For example,
the prevalence of AIDS/HIV decreased as a co-morbidity,
apparently, from 0.6% in 1999 to 0.2% in 2003, when
based on administrative data. However, the Figure 1 was
stable, at 1.0% in 1999 and 0.9% in 2003, when based on
chart review data. The decrease of the positive predictive
value for AIDS/HIV from 100% in 1999 to 66.7% in 2003
could mislead quality of care studies focusing on this co-
morbidity, as might occur if one wanted to study anti-HIV
virus drug utilization, for example. In such studies, the uti-
lization was likely to decrease over the years due to higher
levels of misclassification of non-AIDS/HIV cases, with
33.3% in 2003 compared to 0% in 1999. Therefore, trend
accuracy in the study period should, when possible, be
considered in the interpretation of such studies.
Our study has several limitations. First, we used chart
data as the reference standard to evaluate the validity of
ICD-10 administrative data. Ideally, validity should be
assessed whether the condition is truly present in a patient
or not. In fact, this standard depends on the quality of
medical charts. However, the extent of clinical information
missing in the charts cannot be determined. Second,
although our sample size was relatively large, it was lim-
ited in view of the low prevalence of most Charlson and
Elixhauser co-morbidities in acute care patients. Actually,
we chose to use similar sample sizes to those of our Cana-
dian colleagues [19]. Thus, estimates of accuracy para-
meters for some rare conditions lacked precision and the
observed changes of indicator values was significant in few
cases only, but most significant changes corresponded to
improvement with time. Third, the accuracy of adminis-
trative data may vary across hospitals [35], and from coun-
try to country. Therefore, generalizability of our findings
to other jurisdictions is not certain and should be assessed
through similar studies in other countries of coding accu-
racy over time. Fourth, the use of only one individual
research nurse to abstract the data from each chart, and 2
individuals in total was another limitation. We examined
inter-rater agreements and further trained the research
nurses. Fifth, there were differences in the number of diag-
nosis codes recorded between the three hospitals. More-
over, the number of patients excluded from the non-
teaching hospital was proportionately much larger than in
the teaching hospitals. Thus, the type of hospital might
influence our results. In addition, we used a convenience
sample, not a representative sample of all hospitals in the
country, the external validity of our results is thus limited.
It is difficult to extend our specific results to other coun-
tries because coding rules are potentially different. For
instance, the number of coded diagnoses varies between
countries and could constitute a bias for international
comparisons [36]. However, comparisons could be possi-
ble between countries using a selection of co-morbidities
like Charlson co-morbidities [37]. Nevertheless, beyond
the specific figure, the phenomenon is worth noting and is
of relevance to all jurisdictions introducing new coding
systems. Improved administrative data accuracy may relate
to a coding ‘learning curve’ with the new coding system.
In addition, as coding rules are being adapted constantly,
e.g., in relation with DRG reimbursement schemes, one
cannot take for granted that the measure of cormibidty is
stable over the years.
However, our study has some strength. This is, to our
knowledge, the first study assessing the evolution of
accuracy of co-morbidity information derived from
administrative data, measured at three time points over a
five-year period shortly after the introduction of ICD-10.
In an attempt to represent national hospital discharge
data, we included both teaching and non-teaching hospi-
tals because the validity of administrative data can vary
by type of hospital [34]. Possible further investigations
could include using the patient as the unit of analysis
instead of each co-morbiditiy independently. This will
constitute a different approach to the validity issue of
administrative data.
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Conclusions
Our study demonstrates that the accuracy and reliability
of co-morbidity information from ICD-10 administrative
data improved slightly between 1999 and 2003. This
improvement may be related to higher adherence to
coding standards and systematic use of professional
coders in Swiss hospitals over these years. This finding
indicates that other countries should consider similar
data accuracy assessments over time as new coding sys-
tems are introduced.
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